Found: 4
Select item for more details and to access through your institution.
Safety and efficacy of first-in-man intrathecal injection of human astrocytes (AstroRx®) in ALS patients: phase I/IIa clinical trial results.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-03903-3
- By:
- Publication type:
- Article
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 343, doi. 10.1007/s00228-018-2594-2
- By:
- Publication type:
- Article
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects.
- Published in:
- Molecular Diagnosis & Therapy, 2017, v. 21, n. 1, p. 75, doi. 10.1007/s40291-016-0247-7
- By:
- Publication type:
- Article
Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1187, doi. 10.1007/s40262-022-01141-2
- By:
- Publication type:
- Article